Category
Primary
pharmaceutical-drugs · embed-ft 0.46
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
DOJOLVI® (triheptanoin) | LC Fatty Acid Oxidation Disorder
Description
DOJOLVI® (triheptanoin) is the first and only FDA approved treatment for patients diagnosed with long chain fatty acid oxidation disorders (LC-FAOD)
Final URL
Language
en (html)
Scanned at
2026-06-21 06:27:03